Quality by Design Based Pharmaceutical Development Report of Cost-effective Dexamethasone Tablets, 20 mg for Regulatory Submission

Packiaraj Jeyachandran Manohari, Venkateswaran Chidambaram Seshadri, Induprasad Munirathnam, Aravind Aari Ramesh, Janakiraman Kunchithapatham, Saba Maanvizhi

Open source

DOI: 10.9734/jpri/2025/v37i57696
Published: 2025-05-19
Container: Journal of Pharmaceutical Research International
Publisher: Sciencedomain International
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.9734/jpri/2025/v37i57696,
  title = {Quality by Design Based Pharmaceutical Development Report of Cost-effective Dexamethasone Tablets, 20 mg for Regulatory Submission},
  author = {Packiaraj Jeyachandran Manohari and Venkateswaran Chidambaram Seshadri and Induprasad Munirathnam and Aravind Aari Ramesh and Janakiraman Kunchithapatham and Saba Maanvizhi},
  year = {2025},
  journal = {Journal of Pharmaceutical Research International},
  doi = {10.9734/jpri/2025/v37i57696},
  url = {https://doi.org/10.9734/jpri/2025/v37i57696}
}

RIS

TY  - JOUR
TI  - Quality by Design Based Pharmaceutical Development Report of Cost-effective Dexamethasone Tablets, 20 mg for Regulatory Submission
AU  - Packiaraj Jeyachandran Manohari
AU  - Venkateswaran Chidambaram Seshadri
AU  - Induprasad Munirathnam
AU  - Aravind Aari Ramesh
AU  - Janakiraman Kunchithapatham
AU  - Saba Maanvizhi
PY  - 2025
JO  - Journal of Pharmaceutical Research International
DO  - 10.9734/jpri/2025/v37i57696
UR  - https://doi.org/10.9734/jpri/2025/v37i57696
ER  -

APA

Manohari, P. J., Seshadri, V. C., Munirathnam, I., Ramesh, A. A., Kunchithapatham, J., & Maanvizhi, S. (2025). Quality by Design Based Pharmaceutical Development Report of Cost-effective Dexamethasone Tablets, 20 mg for Regulatory Submission. Journal of Pharmaceutical Research International. https://doi.org/10.9734/jpri/2025/v37i57696

Source records

crossref · retrieved 2026-09-25T22:26:49.542Z